Dysregulation of the polo-like kinase pathway in CD4+ T cells is characteristic of pathogenic simian immunodeficiency virus infection

被引:28
作者
Bostik, P [1 ]
Dodd, GL [1 ]
Villinger, F [1 ]
Mayne, AE [1 ]
Ansari, AA [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
10.1128/JVI.78.3.1464-1472.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD4(+) T-cell dysfunction highlighted by defects within the intracellular signaling cascade and cell cycle has long been characterized as a direct and/or indirect consequence of human immunodeficiency virus (HIV) infection in humans and simian immunodeficiency virus (SIV) infection in rhesus macaques (RM). Dysregulation of the M phase of the cell cycle is a well-documented effect of HIV or SIV infection both in vivo and in vitro. In this study the effect of SIV infection on the modulation of two important regulators of the M phase-polo-like kinases Plk3 and Plk1-was investigated. We have previously shown that Plk3 is markedly downregulated in CD4(+) T cells from SIV-infected disease-susceptible RM but not SIV-infected disease-resistant sooty mangabeys (SM), denoting an association of downregulation with disease progression. Here we show that, in addition to the downregulation, Plk3 exhibits aberrant activation patterns in the CD4(+) T cells from SIV-infected RM following T-cell receptor stimulation. Interestingly, in vitro SIV infection of CD4(+) T cells leads to the upregulation, rather than downregulation, of Plk3, suggesting that different mechanisms operate in vitro and in vivo. In addition, CD4(+) T cells from RM with high viral loads exhibited consistent and significant upregulation of Plk1, concurrent with an aberrant activation-induced Plk1 response, suggesting complex mechanisms of SIV-induced M-phase abnormalities in vivo. Altogether this study presents a novel mechanism underlying M-phase defects observed in CD4(+) T cells from HIV or SIV-infected disease-susceptible humans and RM which may contribute to aberrant T-cell responses and disease pathogenesis.
引用
收藏
页码:1464 / 1472
页数:9
相关论文
共 54 条
[31]   PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression [J].
Kotani, S ;
Tugendreich, S ;
Fujii, M ;
Jorgensen, PM ;
Watanabe, N ;
Hoog, C ;
Hieter, P ;
Todokoro, K .
MOLECULAR CELL, 1998, 1 (03) :371-380
[32]   prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas [J].
Li, B ;
Ouyang, B ;
Pan, HQ ;
Reissmann, PT ;
Slamon, DJ ;
Arceci, R ;
Lu, L ;
Dai, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19402-19408
[33]   Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA [J].
Liu, XQ ;
Erikson, RL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (13) :8672-8676
[34]   HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle [J].
Mahalingam, S ;
Ayyavoo, V ;
Patel, M ;
Kieber-Emmons, T ;
Kao, GD ;
Muschel, RJ ;
Weiner, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3419-3424
[35]   HIV accessory proteins as therapeutic targets [J].
Miller, RH ;
Sarver, N .
NATURE MEDICINE, 1997, 3 (04) :389-394
[36]   Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection [J].
Mori, K ;
Yasutomi, Y ;
Sawada, S ;
Villinger, F ;
Sugama, K ;
Rosenwith, B ;
Heeney, JL ;
Überla, K ;
Yamazaki, S ;
Ansari, AA ;
Rübsamen-Waigmann, H .
JOURNAL OF VIROLOGY, 2000, 74 (13) :5747-5753
[37]   Polo-like kinases: positive regulators of cell division from start to finish [J].
Nigg, EA .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (06) :776-783
[38]   Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals [J].
Paiardini, M ;
Galati, D ;
Cervasi, B ;
Cannavo, G ;
Galluzzi, L ;
Montroni, M ;
Guetard, D ;
Magnani, M ;
Piedimonte, G ;
Silvestri, G .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10843-10855
[39]   Mitotic and G(2) checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 [J].
Peng, CY ;
Graves, PR ;
Thoma, RS ;
Wu, ZQ ;
Shaw, AS ;
PiwnicaWorms, H .
SCIENCE, 1997, 277 (5331) :1501-1505
[40]   Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients [J].
Piedimonte, G ;
Corsi, D ;
Paiardini, M ;
Cannavò, G ;
Ientile, R ;
Picerno, I ;
Montroni, M ;
Silvestri, G ;
Magnani, M .
AIDS, 1999, 13 (10) :1159-1164